December 10th & 11th, 2026
15th edition
MARSEILLE, FR
Stand D8

2026 Edition

SYNGULON

Belgium

Syngulon is a synthetic biology startup that develops original genetic technologies using bacteriocins with core applications:
1. Antibiotic-free genetic selection – sustainable alternatives to antibiotic resistance markers for recombinant protein production. March 2026: we announced a non-exclusive licensing agreement with Elanco Animal Health.
2. Next-generation antimicrobials – novel bacteriocin-based molecules offering targeted strategies against resistant pathogens (on-going project in AH).

Scroll to Top

Before you leave…

Download the official BioFIT 2026 brochure

Discover the conference programme, partnership opportunities, attendee profiles, registration options and everything you need to make the most of BioFIT 2026.